Actelion says wins Japanese approval for heart and lung drug

ZURICH (Reuters) - Actelion said on Thursday the Japanese health regulator approved Opsumit, its new treatment for pulmonary arterial hypertension (PAH).

via Reuters: Health News Read More Here..